XML 108 R95.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Disaggregation of Revenue [Line Items]        
Revenues $ 2,111 $ 2,138 $ 6,238 $ 5,814
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 941 976 2,775 2,700
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 469 432 1,393 1,086
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 409 374 1,115 1,040
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 269 329 884 908
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 23 27 71 80
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 949 916 2,764 2,468
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 120 137 379 371
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 396 360 1,175 921
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 365 341 1,010 957
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 61 71 180 196
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 7 7 20 23
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 527 496 1,515 1,377
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 525 494 1,509 1,374
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 2 2 6 3
International Rx        
Disaggregation of Revenue [Line Items]        
Revenues 271 308 890 848
International Rx | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 61 64 187 185
International Rx | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International Rx | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 41 31 98 77
International Rx | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 161 204 579 553
International Rx | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 8 9 26 33
Ortho Dermatologics        
Disaggregation of Revenue [Line Items]        
Revenues 140 143 418 391
Ortho Dermatologics | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 62 65 186 211
Ortho Dermatologics | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 73 72 218 165
Ortho Dermatologics | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Ortho Dermatologics | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Ortho Dermatologics | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 5 6 14 15
Diversified Products        
Disaggregation of Revenue [Line Items]        
Revenues 224 275 651 730
Diversified Products | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 173 216 514 559
Diversified Products | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified Products | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 3 2 7 6
Diversified Products | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 47 54 125 159
Diversified Products | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 1 $ 3 $ 5 $ 6